BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ?

Phase 4

Completed

Conditions: Cardiac Arrest

First Posted Date: 2005-09-16

Last Posted Date: 2017-02-23

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 200

Registration Number: NCT00180362

Locations: 🇩🇪
Allg. Krankenhaus St. Georg, Hamburg, Germany

Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead

Phase 2

Completed

Conditions: Congestive Heart Failure

First Posted Date: 2005-09-12

Last Posted Date: 2007-06-25

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 115

Registration Number: NCT00158938

EASYTRAK 4 Steerable LV Lead

Phase 2

Completed

Conditions: Heart Failure

First Posted Date: 2005-09-12

Last Posted Date: 2007-06-25

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 110

Registration Number: NCT00158964

Locations: 🇺🇸
Multiple locations, St.Paul, Minnesota, United States

VAST - Ventricular Arrhythmia Suppression Trial

Phase 4

Completed

Conditions: Tachycardia

First Posted Date: 2005-09-12

Last Posted Date: 2006-11-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 550

Registration Number: NCT00158912

CONTAK RENEWAL 3 AVT

Phase 3

Completed

Conditions: Heart Failure
Atrial Fibrillation

First Posted Date: 2005-09-12

Last Posted Date: 2011-09-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 73

Registration Number: NCT00158977

Locations: 🇺🇸
Multiple locations in the US, St Paul, Minnesota, United States

The EASYTRAK EPI Clinical Investigation

Not Applicable

Completed

Conditions: Bradycardia
Congestive Heart Failure

Interventions: Device: EASYTRAK EPI lead

First Posted Date: 2005-09-12

Last Posted Date: 2017-05-31

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT00158925

Locations: 🇺🇸
Multiple Locations in the US, Saint Paul, Minnesota, United States

Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF

Phase 2

Completed

Conditions: Congestive Heart Failure

First Posted Date: 2005-09-12

Last Posted Date: 2007-06-25

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 360

Registration Number: NCT00158951

Locations: 🇺🇸
Multiple Locations in the US, St. Paul, Minnesota, United States

INTRINSIC RV - Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs

Phase 4

Completed

Conditions: Tachycardia

First Posted Date: 2005-09-08

Last Posted Date: 2006-11-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1535

Registration Number: NCT00148967

RIGHT: Rhythm ID Going Head-to-Head Trial

Phase 4

Completed

Conditions: Tachycardia

Interventions: Device: VITALITY 2 Implantable Cardioverter Defibrillator
Device: Medtronic Implantable Cardioverter Defibrillator

First Posted Date: 2005-09-08

Last Posted Date: 2012-01-12

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1962

Registration Number: NCT00148954

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance

Phase 4

Completed

Conditions: Arrhythmia

First Posted Date: 2005-09-07

Last Posted Date: 2017-02-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1500

Registration Number: NCT00146822

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy